Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 |
|---|---|---|---|---|---|---|
| Revenue | 100M | 111M | 107M | 113M | 118M | 88M |
| Cost of revenue | 71M | 75M | 72M | 73M | 77M | 69M |
| Gross profit | 29M | 36M | 36M | 39M | 41M | 20M |
| Research and development | 8M | 6M | 7M | 8M | 10M | 10M |
| Selling, general and administrative | 20M | 22M | 23M | 22M | 21M | 25M |
| Operating expenses | 28M | 29M | 30M | 30M | 33M | 35M |
| Operating income | 939,000 | 7M | 5M | 9M | 8M | −16M |
| Pre-tax income | −2M | 8M | 3M | 5M | 6M | −17M |
| Income tax | −244,000 | 2M | 2M | 1M | 2M | −6M |
| Net income | −2M | 6M | 162,000 | 4M | 4M | −12M |
| Earnings per share | −0.16 | 0.44 | 0.01 | 0.28 | 0.35 | −0.94 |
| Earnings per share, diluted | −0.16 | 0.44 | 0.01 | 0.27 | 0.35 | −0.94 |
| Weighted average shares | 13M | 13M | 13M | 13M | 13M | 13M |
| Weighted average shares, diluted | 13M | 13M | 13M | 13M | 13M | 13M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 78M | 86M | 65M | 60M | 49M | 53M | 52M | 65M |
| Receivables | 188M | 203M | 180M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | — | −12M | — | — | −27M |
| Depreciation and amortisation | 700,000 | 900,000 | 463,000 | 1M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 180M |
| 178M |
| 167M |
| 169M |
| 158M |
| Current assets | 450M | 494M | 475M | 464M | 457M | 423M | 427M | 405M |
| Property, plant and equipment | 19M | 19M | 19M | 17M | 16M | 14M | 12M | 9M |
| Goodwill | 19M | 20M | 19M | 20M | 19M | 18M | 15M | 8M |
| Total assets | 617M | 659M | 643M | 633M | 628M | 594M | 591M | 535M |
| Current liabilities | 226M | 267M | 258M | 282M | 282M | 252M | 248M | 219M |
| Short-term debt | 6M | 4M | 4M | 19M | 4M | 4M | 2M | 2M |
| Long-term debt | 99M | 101M | 102M | 69M | 70M | 71M | 81M | 46M |
| Total liabilities | 345M | 388M | 380M | 370M | 372M | 345M | 344M | 279M |
| Equity | 272M | 272M | 264M | 263M | 256M | 250M | 247M | 256M |
| Shares outstanding | 13M | 13M | 13M | 13M | 13M | 13M | 13M | 13M |
| Shares issued | 13M | 13M | 13M | 13M | 13M | 13M | 13M | 13M |
| Treasury shares | 300,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 |
| 2M |
| 1M |
| Share-based compensation | — | — | 2M | — | — | 2M |
| Capital expenditure | — | — | 2M | — | — | 5M |
| Investing cash flow | — | — | −2M | — | — | −21M |
| Financing cash flow | — | — | 19M | — | — | 34M |